Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
ISSN 0008-5472
J.HubeB
Cereghetti GM, Stangherlin A, Martins de Brito O, Chang CR, Blackstone C, Bernardi P, et al
Despite substantial progress in therapeutic interventions, recurrence rates persist at elevated levels, Individuals presenting with relapsed or refractory B-ALL exhibit significantly reduced rates of remission, with an overall five-year survival probability of merely 20% 2,3
US$ 27.15
US$ 22.60
US$ 20.96
US$ 27.07
US$ 27.53
US$ 23.09
